What's new: newly approved drugs for children

Pediatr Rev. 2001 Oct;22(10):357-9. doi: 10.1542/pir.22-10-357.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age Factors
  • Albuterol / analogs & derivatives
  • Albuterol / therapeutic use
  • Androstadienes / therapeutic use
  • Anticonvulsants / therapeutic use
  • Asthma / drug therapy
  • Asthma / prevention & control
  • Atovaquone
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Beclomethasone / therapeutic use
  • Carbamazepine / analogs & derivatives*
  • Carbamazepine / therapeutic use
  • Child
  • Delayed-Action Preparations
  • Diabetes Mellitus, Type 1 / drug therapy
  • Drug Approval / statistics & numerical data*
  • Drug Combinations
  • Drug Delivery Systems
  • Drug Therapy / standards*
  • Epilepsies, Partial / drug therapy
  • Fluticasone-Salmeterol Drug Combination
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin, Long-Acting
  • Lopinavir
  • Methylphenidate / therapeutic use
  • Naphthoquinones / therapeutic use
  • Nebulizers and Vaporizers
  • Oxcarbazepine
  • Pediatrics / methods*
  • Proguanil / therapeutic use
  • Pyrimidinones / therapeutic use
  • Ritonavir / therapeutic use
  • United States

Substances

  • Androstadienes
  • Anticonvulsants
  • Delayed-Action Preparations
  • Drug Combinations
  • Fluticasone-Salmeterol Drug Combination
  • HIV Protease Inhibitors
  • Insulin
  • Insulin, Long-Acting
  • Naphthoquinones
  • Pyrimidinones
  • atovaquone, proguanil drug combination
  • Methylphenidate
  • Lopinavir
  • Insulin Glargine
  • Carbamazepine
  • Beclomethasone
  • Ritonavir
  • Albuterol
  • Proguanil
  • Oxcarbazepine
  • Atovaquone